chrX-91877251-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_032968.5(PCDH11X):āc.1011A>Gā(p.Ala337=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0022 ( 1 hom., 30 hem., cov: 14)
Exomes š: 0.00030 ( 1 hom. 57 hem. )
Consequence
PCDH11X
NM_032968.5 synonymous
NM_032968.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.147
Genes affected
PCDH11X (HGNC:8656): (protocadherin 11 X-linked) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein consists of an extracellular domain containing 7 cadherin repeats, a transmembrane domain and a cytoplasmic tail that differs from those of the classical cadherins. The gene is located in a major X/Y block of homology and its Y homolog, despite divergence leading to coding region changes, is the most closely related cadherin family member. The protein is thought to play a fundamental role in cell-cell recognition essential for the segmental development and function of the central nervous system. Disruption of this gene may be associated with developmental dyslexia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-91877251-A-G is Benign according to our data. Variant chrX-91877251-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 724999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.147 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 30 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH11X | NM_032968.5 | c.1011A>G | p.Ala337= | synonymous_variant | 6/11 | ENST00000682573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH11X | ENST00000682573.1 | c.1011A>G | p.Ala337= | synonymous_variant | 6/11 | NM_032968.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00219 AC: 201AN: 91806Hom.: 1 Cov.: 14 AF XY: 0.00186 AC XY: 32AN XY: 17180
GnomAD3 genomes
AF:
AC:
201
AN:
91806
Hom.:
Cov.:
14
AF XY:
AC XY:
32
AN XY:
17180
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000783 AC: 81AN: 103477Hom.: 0 AF XY: 0.000397 AC XY: 11AN XY: 27701
GnomAD3 exomes
AF:
AC:
81
AN:
103477
Hom.:
AF XY:
AC XY:
11
AN XY:
27701
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000297 AC: 291AN: 981124Hom.: 1 Cov.: 19 AF XY: 0.000199 AC XY: 57AN XY: 286872
GnomAD4 exome
AF:
AC:
291
AN:
981124
Hom.:
Cov.:
19
AF XY:
AC XY:
57
AN XY:
286872
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00219 AC: 201AN: 91843Hom.: 1 Cov.: 14 AF XY: 0.00174 AC XY: 30AN XY: 17231
GnomAD4 genome
AF:
AC:
201
AN:
91843
Hom.:
Cov.:
14
AF XY:
AC XY:
30
AN XY:
17231
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at